Health Services Research
Monday, May 18
IP74-01: Healthcare Utilization and Expenditure Burden in Bladder Cancer: A Nationally Representative Analysis (MEPS 2015–2022)
IP74-02: Predictors of Phase-Based Costs of Bladder Cancer Care in a Universal Healthcare System
IP74-03: COSTS OF CARE AND ONCOLOGIC OUTCOMES ASSOCIATED WITH BLUE LIGHT CYSTOSCOPY IN AN EQUAL ACCESS SETTING: RESULTS FROM THE BRAVO STUDY
IP74-04: Updated Analysis of Cost-Effectiveness Among Bladder-Sparing Treatments for BCG-Unresponsive CIS: Incorporating Recently Approved and Established Therapies
IP74-05: Initial validation of an automated large language model pipeline for population-scale extraction of bladder pathology reports
IP74-06: IMPROVING VALUE IN HEMATURIA EVALUATION THROUGH URINE BIOMARKER TESTING: A COST-UTILITY ANALYSIS OF ASSUREMDX
IP74-07: Predicting the Unplanned: A Low-Burden Machine Learning Model to Predict 30-Day ED Visits After Cystectomy
IP74-08: Assessing Health and Health Services Use among Genitourinary Cancer Survivors in the Post-COVID pandemic Period Using MEPS Data
IP74-09: Cost Comparison of Office-Based and Operating Room Intradetrusor OnabotulinumtoxinA Injections for Overactive Bladder
IP74-10: timing of minimally invasive therapy initiation for overactive bladder: impact on health care utilization and costs in the Medicare population, 2018-2024
IP74-11: Evaluation of Operative Characteristics and Cost Using the ClearPetra Suction Sheath
IP74-12: Preliminary Cost Analysis of Flexible Navigable Suction Sheaths (FANS) versus Standard Ureteroscopy in Kidney Stone Treatment: A Pilot Comparative Study
IP74-13: Structured Triage Pathway for Renal Colic: A Cost-Effective Model to Reduce Hospital Admissions, Emergency Surgeries, and Length of Stay
IP74-14: MyUrology Health: Clinical, Quality, and Cost-Savings Outcomes from a Novel Value-Based Payment Model for Nephrolithiasis Care
IP74-15: Kidney Stone Program (KSP): Financial and Operational value of an Integrated centralized program
IP74-16: From Data to Decision Support: Predicting Post-Emergency Department Renal Colic Outcomes Using a Harmonized Electronic Health Record Framework
IP74-17: Economic Implications of Reduced Prostate Cancer Screening Among Men Enrolled in High-Deductible Health Plans
IP74-18: Ten-year experience transitioning from magnetic resonance imaging (MRI)-guided transrectal to transperineal prostate biopsies: Rising pathology costs, time burden, and scenarios for increased efficiency
IP74-19: The Impact of a Generic Alternative on Medicare Part D Spending for Abiraterone
IP74-20: Development of an individualized price transparency tool for patients with metastatic prostate cancer: a pilot study
IP74-21: System-Level Price Transparency Drives Patient Trust: Insights from a Urology Patient Survey
IP74-22: Safety, Efficiency and Environmental Impact of Virtual At-Home Catheter Removal Following Robotic-Assisted Radical Prostatectomy
IP74-23: An Analysis of Sales of the Intuitive Single-Port Robotic System Compared to the Multi-Port Platform
IP74-24: Administrative Cost Weights Are Unreliable Surrogates for True Surgical Cost: A Validation Study in Robotic Nephrectomy
IP74-25: Characterization of costs, discounts, and payment plans for patients seeking urologic appointments – a national cross-sectional study
IP74-26: Uncovering the Drivers of Urology Reimbursement Variation Across the United States
IP74-27: Differences in Surgical Outcomes Between Dually Eligible and Medicare-Only Beneficiaries After Major Urologic Cancer Surgery, 2010–2021
IP74-28: The Effect of Centralization on Perioperative Mortality for Urologic Cancer Surgery
IP74-29: Long-term impacts of COVID-19 health system disruptions on outcomes following major cancer surgery
IP74-30: Cost comparison between sutureless and renorrhaphy off-clamp robotic partial nephrectomy: results from a single-center randomized controlled trial
Registered attendees
KS
Kristian Stensland
Assistant ProfessorUniversity of Michigan